Metformin causes gastrointestinal side effects in roughly 20% of people who take it. The most common complaints are diarrhea, nausea, vomiting, abdominal pain, and bloating. These usually appear when you first start the medication and often improve on their own as your body adjusts over the first few weeks.
Digestive Side Effects Are the Most Common
Stomach and bowel issues are far and away the top reason people struggle with metformin. About 1 in 5 users experience some combination of diarrhea, nausea, vomiting, stomach cramps, bloating, or loss of appetite. Diarrhea tends to be the most frequently reported of the group.
These symptoms are most intense during the first days and weeks of treatment. For most people, they fade as the body adapts. This is why prescribers typically start you on a low dose and increase it gradually. A common approach is to begin with a single 500mg tablet taken with breakfast for at least a week, then add a second dose with dinner the following week, and eventually work up to three doses with meals. Taking metformin with food, or just after eating, also makes a noticeable difference in how your stomach handles it.
If side effects persist even after a gradual ramp-up, switching to a slow-release (extended-release) version of metformin often helps. The extended-release tablet delivers the drug more gradually, which is gentler on the gut. Some people who couldn’t tolerate the standard version do well on this formulation.
Metallic Taste
Some people notice an unusual metallic or bitter taste in their mouth after starting metformin. This is an acknowledged side effect, sometimes called dysgeusia. It tends to be more of an annoyance than a health concern and, like the digestive symptoms, often fades with continued use.
Weight Loss
Metformin frequently causes modest weight loss, which for many people is a welcome change rather than a problem. In the large Diabetes Prevention Program study, participants taking metformin lost an average of about 2.1 kg (roughly 4.5 pounds) in the first year. That weight loss held up over long-term follow-up, averaging around 2.5 kg over a decade. People who took their medication consistently lost more, averaging about 3.1 kg (close to 7 pounds). The effect is real but not dramatic. A separate meta-analysis found average weight loss of about 1.5 kg at one year.
This weight reduction is partly why metformin is sometimes prescribed off-label for conditions beyond type 2 diabetes. But if you’re losing weight unexpectedly or rapidly while taking it, that’s worth mentioning to your prescriber since it could also signal that nausea and appetite loss are more severe than they should be.
Vitamin B12 Deficiency
This is one of the less obvious side effects and one that can sneak up on long-term users. Metformin interferes with the body’s ability to absorb vitamin B12 from food. Updated product labeling now classifies B12 deficiency as a “common” adverse reaction, potentially affecting up to 1 in 10 people taking the drug.
B12 deficiency develops slowly, sometimes over years, and the symptoms can be subtle at first: fatigue, weakness, tingling or numbness in the hands and feet, difficulty with balance, or a general mental fogginess. Because these overlap with symptoms of diabetes itself, they’re easy to dismiss or attribute to something else. Left unchecked, low B12 can cause lasting nerve damage.
If you’ve been on metformin for a while, periodic B12 testing is worth discussing, especially if you have other risk factors for deficiency (such as being over 65, following a vegetarian or vegan diet, or having a digestive condition that affects absorption). Catching it early means it can usually be corrected with supplements.
Lactic Acidosis: Rare but Serious
Lactic acidosis is the most dangerous potential complication of metformin, but it is genuinely rare. The reported frequency is about 0.06 per 1,000 patient-years, and it occurs almost exclusively in people who have other predisposing factors, particularly kidney problems. When the kidneys can’t clear metformin efficiently, the drug accumulates and can cause a dangerous buildup of lactic acid in the blood.
Warning signs include unusual muscle pain, difficulty breathing, stomach pain, nausea, vomiting, feeling cold, dizziness, or a sudden change in alertness. These symptoms are nonspecific, meaning they could come from many causes, but if they appear together or feel unusual while you’re on metformin, they warrant urgent medical attention.
This risk is the reason metformin has strict kidney function thresholds. It’s not started in people whose kidney filtration rate (eGFR) falls below 30, and initiation isn’t recommended when eGFR is between 30 and 45. For people already taking it whose kidney function later declines below 45, the prescriber will reassess whether continuing makes sense. If kidney function drops below 30, the drug is stopped.
How to Reduce Side Effects
Most of the discomfort from metformin is front-loaded in the first few weeks and can be managed with a few practical strategies:
- Take it with food. Swallowing your tablet with or right after a meal buffers the impact on your stomach. Taking it with your evening meal in particular seems to help.
- Start low and increase slowly. A gradual dose increase over several weeks gives your digestive system time to adapt. Jumping straight to a full dose is much more likely to cause problems.
- Ask about extended-release tablets. If standard metformin is consistently hard on your stomach even after the adjustment period, the slow-release version delivers the same medication with fewer GI side effects for many people.
- Don’t skip doses to manage symptoms. Inconsistent dosing can make side effects worse each time you restart. If the side effects are severe enough that you’re tempted to skip, that’s a conversation to have with your prescriber about adjusting the approach.
For most people, metformin’s side effects are manageable and temporary. The digestive symptoms that dominate the first few weeks tend to settle down, and the more serious risks remain uncommon as long as kidney function is monitored. The one to keep on your radar long-term is B12, since it develops quietly and is easy to miss without testing.